Thompson Peter A.

CIK 000135752217 companiesBELLEVUE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001357522

Recent Transactions

50 trades

Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-12-19$44.49/sh−875→ 3,595,011 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-12-18$44.49/sh−100→ 3,595,886 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-12-17$44.50/sh−900→ 3,595,986 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-11-26$44.49/sh−1,600→ 3,596,886 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-11-25$44.60/sh−11,890→ 3,598,486 total
Sale
Sionna Therapeutics, Inc.$SION
Common Stock
2025-11-24$44.54/sh−94,583→ 3,610,376 total
Sale
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2025-06-27$4.16/sh−1,176,332→ 7,165,006 total
Exercise of In-Money
Corvus Pharmaceuticals, Inc.$CRVS
Common Warrants (right to buy)
2025-06-27−1,397,684→ 0 total
Exercise of In-Money
Corvus Pharmaceuticals, Inc.$CRVS
Common Stock
2025-06-27$3.50/sh+1,397,684→ 8,341,338 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2025-06-25+30,000→ 30,000 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-06-16+30,000→ 30,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2025-06-12+15,000→ 15,000 total
Award
Sionna Therapeutics, Inc.$SION
Non-Qualified Stock Option (right to buy)
2025-06-12+19,959→ 19,959 total
Purchase
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-04-03$20.13/sh+124,193→ 443,792 total
Purchase
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-04-03$20.13/sh+372,578→ 14,809,075 total
Conversion
Sionna Therapeutics, Inc.$SION
Series C convertible preferred stock
2025-02-10−2,048,760→ 0 total
Conversion
Sionna Therapeutics, Inc.$SION
Common Stock
2025-02-10+3,154,959→ 3,154,959 total
Purchase
Sionna Therapeutics, Inc.$SION
Common Stock
2025-02-10$18.00/sh+550,000→ 3,704,959 total
Conversion
Sionna Therapeutics, Inc.$SION
Series B convertible preferred stock
2025-02-10−2,560,951→ 0 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-26$13.00/sh−83,695→ 0 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-23$13.03/sh−69,500→ 83,695 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-22$12.94/sh−391,482→ 153,195 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-21$13.52/sh−394,400→ 557,977 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-08-21$14.61/sh−13,300→ 544,677 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (right to buy)
2024-06-20+40,000→ 40,000 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2024-06-13+15,000→ 15,000 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Options (Right to buy)
2024-06-10+20,594→ 20,594 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−17,500→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−10,000→ 0 total
Disposition to Issuer
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-05-20−7,650→ 0 total
Disposition from Tender
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-18−2,416,181→ 0 total
Disposition from Tender
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-05-18−264,315→ 0 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Common Warrants (right to buy)
2024-05-06+1,397,684→ 1,397,684 total
Purchase
Corvus Pharmaceuticals, Inc.$CRVS
Pre-Funded Warrants (right to buy)
2024-05-06$1.73/sh+1,444,085→ 1,444,085 total
Purchase
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-01-23$11.00/sh+454,545→ 14,436,497 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2024-01-11$12.74/sh+145,251→ 2,416,181 total
Exercise of In-Money
ALPINE IMMUNE SCIENCES, INC.
Warrant (Right to Buy)
2024-01-11−145,251→ 0 total
Award
ALPINE IMMUNE SCIENCES, INC.
Stock Option (Right to buy)
2024-01-02+17,500→ 17,500 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-28$19.82/sh−3,128→ 403,481 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-28$19.82/sh−26,872→ 3,466,613 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-28$18.32/sh−139,166→ 264,315 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-28$18.32/sh−1,195,683→ 2,270,930 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-27$19.96/sh−18,922→ 406,609 total
Sale
ALPINE IMMUNE SCIENCES, INC.
Common Stock
2023-12-27$19.96/sh−162,576→ 3,493,485 total
Award
Corvus Pharmaceuticals, Inc.$CRVS
Stock Option (Right to Buy)
2023-12-06+15,000→ 15,000 total
Purchase
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2023-08-29$6.20/sh+500,000→ 8,019,187 total

Companies

Recent Filings

Address

14075 NE 30TH PLACE

BELLEVUE, WA, 98005

View on SEC.gov